Moderately Hypofractionated Radiotherapy for Prostate Cancer.

NCT03827616 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
400
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tatarstan Cancer Center